Non-erosive Reflux Disease
📧 Sign up to get email alerts when something new happens for Non-erosive Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Clinical Efficacy Evaluation of Chaizhi Hewei Decoction in the Treatment of Non-Erosive Reflux Disease With Liver-Stomach Disharmony Syndrome [NA]
A clinical trial is evaluating the efficacy of Chaizhi Hewei Decoction for non-erosive reflux disease with liver-stomach disharmony; recruit…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Vonoprazan Test for PPI Refractory GERD [NA]
A clinical trial evaluating vonoprazan for patients with PPI-refractory gastroesophageal reflux disease (refractory GERD) and non-erosive re…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease [Phase 3]
A Phase 3 study assessing the long-term safety of BLI5100 in patients with gastroesophageal reflux disease (including non-erosive reflux dis…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence [NA]
Real-world clinical trial investigating how adherence to behavioral and dietary changes affects Gastroesophageal Reflux Disease manifestatio…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Evaluation of the Efficacy and Safety of Eolo in Patients With NERD [NA]
This update reports the completed clinical trial evaluating the efficacy and safety of Eolo in patients with non-erosive reflux disease and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Cognitive-behavioral Therapy for the Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities. [NA]
A clinical trial exploring cognitive-behavioral therapy for conditions linked to esophageal-brain-gut axis communication abnormalities, curr…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities. [NA]
A recruiting clinical trial from Hualien Tzu Chi General Hospital is evaluating neuroregulators for diseases associated with esophageal-brai…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease [Phase 3]
Phase 3 trial evaluating the efficacy and safety of BLI5100 in non-erosive reflux disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD) [Phase 3]
Phase 3 clinical trial evaluating DWP14012 for non-erosive gastroesophageal reflux disease (NERD) is ongoing with status unknown.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients [Phase 3]
A Phase 3 clinical trial evaluating YYD601 for non-erosive reflux disease has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD [Phase 3]
Phase III study assessing safety and efficacy of ilaprazole in non-erosive reflux disease is completed.
-
CLINICAL_TRIALS trial_result · 2020-07-02Clinical Trial Update: Study on the Rule and Mechanism of Treating Functional Gastrointestinal Diseases From the Perspective of Liver and Spleen [Phase 4]
A Phase 4 clinical trial update evaluating treatment approaches for functional gastrointestinal diseases focusing on liver and spleen perspe…
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the Efficacy and Safety of LXI-15028 in Non-erosive Reflux Disease in Chinese Patients for 4 Weeks [Phase 3]
A Phase 3 randomized, double-blind trial evaluating LXI-15028 for non-erosive reflux disease in Chinese patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg [Phase 4]
Phase 4 trial update for EsoDuo Tab. 20/800mg evaluating efficacy and safety in non-erosive reflux disease (NERD) completed.
-
FDA approval · 2019-11-29FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for Rabeprazole sodium by Advagen Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2019-08-26Clinical Trial Update: Efficacy of Traditional Chinese Medicine Combined With Omeprazole in Patients With Non-erosive Reflux Disease [Phase 1, Phase 2]
Clinical trial update evaluating the efficacy of traditional Chinese medicine combined with omeprazole for non-erosive reflux disease across…
-
CLINICAL_TRIALS trial_result · 2018-04-04Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease [Phase 3]
This document reports the completion of a Phase 3 study evaluating the safety and efficacy of CJ-12420 in patients with non-erosive reflux d…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Assessment of Esophageal Epithelium Integrity With Mucosal Impedance [NA]
This clinical trial update indicates that the study evaluating esophageal epithelium integrity using mucosal impedance in GERD and NERD pati…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Functional Gastrointestinal Disorder Screening Program - A Randomized Controlled Trial [NA]
This update reports the completion of a randomized controlled trial evaluating a functional gastrointestinal disorder screening program. The…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases [Phase 3]
Phase III results for D961H at 10 mg and 20 mg in Japanese pediatric patients with gastrointestinal acid-related diseases have been complete…
-
FDA approval · 2016-12-01FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) from AmerisourceBergen, updating labeling and…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: A Study of the Effect of ONO-8539 on Oesophageal Pain Hypersensitivity in Patients With Non-erosive Reflux Disease [Phase 1]
The document notes that ONO-8539 completed a Phase 1 trial assessing its effect on esophageal pain hypersensitivity in patients with non-ero…
-
CLINICAL_TRIALS research · 2014-11-20Clinical Trial Update: The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients [NA]
This clinical trial update reports on changes in Ryodoraku and heart rate variability after proton pump inhibitor treatment in patients with…
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: S-pantoprazole 10mg Phase III Clinical Study [Phase 3]
Phase III trial update for S-pantoprazole 10 mg in non-erosive reflux disease; current status of the trial is unknown.
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD) [Phase 2]
A Phase 2 trial update shows completion of a study evaluating YH1885L for non-erosive reflux disease, assessing safety, tolerability and eff…